# A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight

> **NCT07708493** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3034701 (C-14)

## Key facts

- **NCT ID:** NCT07708493
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-08-24
- **Primary completion:** 2026-10-14
- **Final completion:** 2026-10-14
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708493, "A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*